The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Exagen Inc(NASDAQ:XGN) 
Exagen Inc. develops and commercializes various testing products based on its Cell-Bound Complement Activation Products technology under the AVISE brand in the United States. It enables rheumatologists to enhance care for patients through the diagnosis, prognosis, and monitoring of complex autoimmun...
Website: http://www.exagen.com
Founded: 2002
IPO Price: $14 (Sep 19, 2019)
Full Time Employees: 153
CEO: Fortunato Ron Rocca
Sector: Healthcare
Industry: Diagnostics & Research
Exagen Days Payable Outstanding ttm (DPO)
Exagen Days Receivable Outstanding ttm (DSO)
Exagen Days Inventory Outstanding ttm (DIO)
Exagen Op Cashflow Per Share ttm
Exagen Free Cashflow Per Share ttm
Exagen Cash Per Share ttm
Exagen P/S ratio ttm
Exagen (GAAP) P/E ratio ttm
Exagen P/B ratio ttm
No extra charts and metrics for this ticker.